ACET- Adicet Bio, Inc.
Adicet Bio, Inc. (ACET) has 2 insiders with recent SEC Form 4 filings, including 1 buy and 23 sells. ACET is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.18M | $10.83M | - | |
| 10% | 0 | - | - |
Activity
Buys and sells only
Transactions
10 filings · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Schor Chen79 | President &CEO | Sell | 78,412 | $16.80 | $1,317,221.72 | -18.3% | -40.6% | -90.5% | |
| Aug 3, 2022 | Aftab Blake86 | Chief Scientific Officer | Sell | 6,968 | $18.00 | $125,424.00 | -15.2% | -2.9% | -86.5% | |
| Aug 1, 2022 | Aftab Blake86 | Chief Scientific Officer | Sell | 6,968 | $16.64 | $115,947.52 | -13.2% | -0.1% | -84.7% | |
| Jul 5, 2022 | Aftab Blake86 | Chief Scientific Officer | Sell | 1,363 | $14.50 | $19,763.50 | -2.5% | -3.9% | -79.8% | |
| Apr 4, 2022 | Galimi Francesco | SVP &Chief Medical Officer | Sale+OE | 15,600 | $21.00 | $327,600.00 | -6.1% | -21.0% | -73.0% | |
| Mar 9, 2022 | Jakobovits Aya77 | Director | Sell | 4,000 | $14.00 | $56,000.00 | -0.6% | -7.8% | -48.0% | |
| Feb 16, 2022 | Jakobovits Aya77 | Director | Sell | 4,000 | $14.83 | $59,327.60 | -0.6% | -17.1% | -46.9% | |
| Feb 9, 2022 | Jakobovits Aya77 | Director | Sell | 24,000 | $16.51 | $396,157.40 | -1.1% | -19.1% | -46.5% | |
| Dec 8, 2021 | Sinclair Andrew | Director | Buy | 500,000 | $14.00 | $7,000,000.00 | +30.5% | -14.5% | +30.0% | |
| Jun 16, 2021 | Schor Chen79 | President &CEO | Sell | 16,466 | $10.53 | $173,442.96 | -9.1% | -30.4% | +4.1% |